Akebia Therapeutics Lower Following Announcement Of Public Offering, Corporate And Clinical Developments

By: via Benzinga
Shares of Akebia Therapeutics Inc (NASDAQ: AKBA), a biopharmaceutical company that focuses on products for the treatment of kidney ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.